S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Bas Wouters Files €32 Million Lawsuit Against Robert Cialdini

Dutch behavioral design expert Bas Wouters has initiated a civil claim in the Netherlands seeking approximately €31.99 million in damages. The legal action targets Dr. Robert Cialdini and several U.S.-based associates, centering on allegations of commercial misconduct and disputed share transfers involving the Cialdini Institute.

Bas Wouters Files €32 Million Lawsuit Against Robert Cialdini
Photo: Bio & News

The summons, filed in the Netherlands, names Robert Cialdini, Bobette Gorden, Samir Patel, Christopher Phelps, and their respective entities, Influence At Work LLC and Cialdini Institute LLC, as defendants. Wouters, who played a central role in the institute's international expansion, contends that his shareholder interests and business assets were compromised by the defendants' actions. Central to the filing are claims regarding intellectual property, contractual breaches, and a contested transfer of Wouters’ majority stake in the organization.

Tim Delmée, counsel for Wouters, confirmed that the allegations are detailed in the formal summons, noting that the defendants will have the opportunity to contest these claims in court. As of now, no judicial authority has ruled on the merits of the case. The legal proceedings remain ongoing, with a comprehensive set of exhibits and documentation provided by the plaintiff now available for public review via a dedicated case portal.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!